Sondelbay
Analogs of Sondelbay
Find cheaper analogs and generic equivalents for Sondelbay.
Active Ingredient: teriparatide
Product Overview
About Sondelbay
Sondelbay contains the active substance teriparatide and was to be available as a solution for injection in prefilled pens.
What it is used for
Sondelbay was to be used for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. It was also to be used in men and women who are at an increased risk of fractures due to long-term treatment with glucocorticoids (a type of steroid).
How it works
Osteoporosis happens when not enough new bone grows to replace the bone that is naturally broken down, as may happen in women after the menopause. Gradually, the bones become fragile, and more likely to break. Osteoporosis can also occur in both sexes as a side effect of glucocorticoid treatment. The active substance in Sondelbay, teriparatide, is identical to part of the human parathyroid hormone and acts on osteoblasts (bone-forming cells) in a similar way to stimulate bone formation. It also increases the absorption of calcium from food and prevents too much calcium being lost in the urine. Sondelbay was a ‘biosimilar medicine’. This means that it was expected to be highly similar to another biological medicine (the ‘reference medicine’) that is already authorised in the EU. The reference medicine for Sondelbay was Forsteo.
Active substance: teriparatide
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
